Fatemeh Moradi

High Impact

Researcher

UAMS

Also affiliated: Islamic Azad University, Tehran (2021–2023); Isfahan University of Medical Sciences (2022–2024); Zanjan University of Medical Sciences (2017–2025); Volgograd State Medical University (2020); Amirkabir University of Technology (2023–2024); Universität Hamburg (2023); Iran University of Medical Sciences (2014–2025); Mashhad University of Medical Sciences (2022); Isfahan University of Technology (2022–2025); Damghan University (2012); Shiraz University of Medical Sciences (2022); Allameh Tabataba'i University (2023–2024); University of Tehran (2013–2022); Abdelmalek Essaâdi University (2022); Iran National Science Foundation (2013); University of Arkansas Medical Center (2025–2026); Kermanshah University of Medical Sciences (2015–2025); Aerospace Research Institute (2024–2025); Stem Cell Technology Research Center (2020); Hormozgan University of Medical Sciences (2017); Habib University (2022); National Institute of Genetic Engineering and Biotechnology (2025); Bio-Medical Science (South Korea) (2018); Fasa University of Medical Sciences (2016–2022); Rowan University (2025); Shahid Beheshti University (2012); Shahid Beheshti University of Medical Sciences (2023); Qazvin University of Medical Sciences (2018); Tehran University of Medical Sciences (1996–2022); Mazandaran University of Medical Sciences (2022–2023); Hamburg University of Technology (2023); Baidu (China) (2022)

Faculty Researcher

22 h-index 142 pubs 1,555 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Fatemeh Moradi's research focuses on the development of therapeutic strategies for neurological diseases, including Alzheimer's disease and Parkinson's disease, as well as spinal cord injuries. Her work involves the investigation of neuroinflammation and the delivery of therapeutic agents, such as nanoparticles and stem cells, through various routes, including intranasal administration. Moradi has explored the potential of three-dimensional-printed scaffolds for promoting neural regeneration and has conducted in silico studies to identify natural and synthetic compounds that interact with key proteins involved in Alzheimer's disease, aiming to design new therapeutic agents.

Her scholarly output includes a significant body of work, reflected in an h-index of 22 and over 1,500 citations. Moradi has published on a range of topics, from the fusion of visible-thermal UAV imagery for tree detection using convolutional neural networks to the effects of nutrition training on medical students and the impact of tart cherry juice on cardio-metabolic risk factors. She collaborates with researchers at the University of Arkansas for Medical Sciences, including C. G. Shashank, Neha S. Dole, Amy Y. Sato, and Ryan M. Allen, evidenced by shared publications.

Metrics

h-index: 22
Publications: 142
Citations: 1,555

Selected Publications

Corrigendum to: Potential Anti-inflammatory Properties of Corydalis rhizoma for Co-Treatment of Neuropathic Pain and Major Depressive Disorder: Network Pharmacology with Molecular Docking and Molecular Dynamics Simulation Approaches (2026)

Current Topics in Medicinal Chemistry DOI OpenAlex
Osteocytic Lipocalin-2 regulates bone formation locally through iron-dependent ferroptosis and Wnt suppression (2026)

Cell Death Discovery DOI OpenAlex
Neurological Manifestations in Primary Sjögren’s Syndrome: A Comparative Review of Inflammatory Mechanisms (2025)

Journal of Contemporary Medical Sciences DOI OpenAlex
Potential Anti-inflammatory Properties of Corydalis rhizoma for Co-Treatment of Neuropathic Pain and Major Depressive Disorder: Network Pharmacology with Molecular Docking and Molecular Dynamics Simulation Approaches (2025)

Current Topics in Medicinal Chemistry 4 citations DOI OpenAlex